Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease

Though promoting remyelination in multiple sclerosis (MS) has emerged as a promising therapeutic strategy, it does not address inflammatory signals that continue to induce neuronal damage and inhibit effectiveness of repair mechanisms. Our lab has previously characterized the immunomodulatory tetrap...

Full description

Saved in:
Bibliographic Details
Published in:Front Immunol
Main Authors: Thompson, Kaitlyn K., Nissen, Jillian C., Pretory, Amanda, Tsirka, Stella E.
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2018
Subjects:
Immunology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6283261/
https://ncbi.nlm.nih.gov/pubmed/30555470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02784
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items